Cargando…

How Do Institutional Conflicts of Interest Between Pharmaceutical Companies and the Healthcare Sector Become Corrupt? A Case Study of Scholarship Donations Between Department of Clinical Anesthesiology, Mie University, and Ono Pharmaceutical in Japan

Institutional conflicts of interest (ICOIs) with pharmaceutical companies can bias internal operation of healthcare organizations. Naturally, a scholarship donation—which is a donation scheme unique to Japan, provided to healthcare organizations and their subunits to encourage educational and academ...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozaki, Akihiko, Murayama, Anju, Harada, Kayo, Saito, Hiroaki, Sawano, Toyoaki, Tanimoto, Tetsuya, Ozieranski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761953/
https://www.ncbi.nlm.nih.gov/pubmed/35047471
http://dx.doi.org/10.3389/fpubh.2021.762637
_version_ 1784633651488620544
author Ozaki, Akihiko
Murayama, Anju
Harada, Kayo
Saito, Hiroaki
Sawano, Toyoaki
Tanimoto, Tetsuya
Ozieranski, Piotr
author_facet Ozaki, Akihiko
Murayama, Anju
Harada, Kayo
Saito, Hiroaki
Sawano, Toyoaki
Tanimoto, Tetsuya
Ozieranski, Piotr
author_sort Ozaki, Akihiko
collection PubMed
description Institutional conflicts of interest (ICOIs) with pharmaceutical companies can bias internal operation of healthcare organizations. Naturally, a scholarship donation—which is a donation scheme unique to Japan, provided to healthcare organizations and their subunits to encourage educational and academic activities related to the development of new drugs—fall into the ICOI category. While anecdotal evidence exists that scholarship donations have been used as bribes by pharmaceutical companies, there has been little case study research that would illuminate the workings of this “gray area” mechanism. From this perspective, we offer an in-depth analysis of a recent scandal involving the Department of Clinical Anesthesiology, Mie University and Ono Pharmaceutical, where a scholarship donation was used by a pharmaceutical company to increase the prescription of one of its key drugs at a hospital department. Available evidence also suggests that a professor based within the department originally requested a scholarship donation from the company, which became an initial trigger of the scandal. We argue that by scrutinizing scholarship donations we can gain insight into problems specific to ICOIs between the pharmaceutical companies and the healthcare sector in Japan. In addition, scholarship donations can be understood as a form of “gifts” which have been found to underpin certain forms of pharmaceutical companies' promotional activities in Japan but also in other countries. We conclude by highlighting potential institutional remedies, which may alleviate ICOIs and corrupt behavior affecting the healthcare sector.
format Online
Article
Text
id pubmed-8761953
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87619532022-01-18 How Do Institutional Conflicts of Interest Between Pharmaceutical Companies and the Healthcare Sector Become Corrupt? A Case Study of Scholarship Donations Between Department of Clinical Anesthesiology, Mie University, and Ono Pharmaceutical in Japan Ozaki, Akihiko Murayama, Anju Harada, Kayo Saito, Hiroaki Sawano, Toyoaki Tanimoto, Tetsuya Ozieranski, Piotr Front Public Health Public Health Institutional conflicts of interest (ICOIs) with pharmaceutical companies can bias internal operation of healthcare organizations. Naturally, a scholarship donation—which is a donation scheme unique to Japan, provided to healthcare organizations and their subunits to encourage educational and academic activities related to the development of new drugs—fall into the ICOI category. While anecdotal evidence exists that scholarship donations have been used as bribes by pharmaceutical companies, there has been little case study research that would illuminate the workings of this “gray area” mechanism. From this perspective, we offer an in-depth analysis of a recent scandal involving the Department of Clinical Anesthesiology, Mie University and Ono Pharmaceutical, where a scholarship donation was used by a pharmaceutical company to increase the prescription of one of its key drugs at a hospital department. Available evidence also suggests that a professor based within the department originally requested a scholarship donation from the company, which became an initial trigger of the scandal. We argue that by scrutinizing scholarship donations we can gain insight into problems specific to ICOIs between the pharmaceutical companies and the healthcare sector in Japan. In addition, scholarship donations can be understood as a form of “gifts” which have been found to underpin certain forms of pharmaceutical companies' promotional activities in Japan but also in other countries. We conclude by highlighting potential institutional remedies, which may alleviate ICOIs and corrupt behavior affecting the healthcare sector. Frontiers Media S.A. 2022-01-03 /pmc/articles/PMC8761953/ /pubmed/35047471 http://dx.doi.org/10.3389/fpubh.2021.762637 Text en Copyright © 2022 Ozaki, Murayama, Harada, Saito, Sawano, Tanimoto and Ozieranski. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Ozaki, Akihiko
Murayama, Anju
Harada, Kayo
Saito, Hiroaki
Sawano, Toyoaki
Tanimoto, Tetsuya
Ozieranski, Piotr
How Do Institutional Conflicts of Interest Between Pharmaceutical Companies and the Healthcare Sector Become Corrupt? A Case Study of Scholarship Donations Between Department of Clinical Anesthesiology, Mie University, and Ono Pharmaceutical in Japan
title How Do Institutional Conflicts of Interest Between Pharmaceutical Companies and the Healthcare Sector Become Corrupt? A Case Study of Scholarship Donations Between Department of Clinical Anesthesiology, Mie University, and Ono Pharmaceutical in Japan
title_full How Do Institutional Conflicts of Interest Between Pharmaceutical Companies and the Healthcare Sector Become Corrupt? A Case Study of Scholarship Donations Between Department of Clinical Anesthesiology, Mie University, and Ono Pharmaceutical in Japan
title_fullStr How Do Institutional Conflicts of Interest Between Pharmaceutical Companies and the Healthcare Sector Become Corrupt? A Case Study of Scholarship Donations Between Department of Clinical Anesthesiology, Mie University, and Ono Pharmaceutical in Japan
title_full_unstemmed How Do Institutional Conflicts of Interest Between Pharmaceutical Companies and the Healthcare Sector Become Corrupt? A Case Study of Scholarship Donations Between Department of Clinical Anesthesiology, Mie University, and Ono Pharmaceutical in Japan
title_short How Do Institutional Conflicts of Interest Between Pharmaceutical Companies and the Healthcare Sector Become Corrupt? A Case Study of Scholarship Donations Between Department of Clinical Anesthesiology, Mie University, and Ono Pharmaceutical in Japan
title_sort how do institutional conflicts of interest between pharmaceutical companies and the healthcare sector become corrupt? a case study of scholarship donations between department of clinical anesthesiology, mie university, and ono pharmaceutical in japan
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761953/
https://www.ncbi.nlm.nih.gov/pubmed/35047471
http://dx.doi.org/10.3389/fpubh.2021.762637
work_keys_str_mv AT ozakiakihiko howdoinstitutionalconflictsofinterestbetweenpharmaceuticalcompaniesandthehealthcaresectorbecomecorruptacasestudyofscholarshipdonationsbetweendepartmentofclinicalanesthesiologymieuniversityandonopharmaceuticalinjapan
AT murayamaanju howdoinstitutionalconflictsofinterestbetweenpharmaceuticalcompaniesandthehealthcaresectorbecomecorruptacasestudyofscholarshipdonationsbetweendepartmentofclinicalanesthesiologymieuniversityandonopharmaceuticalinjapan
AT haradakayo howdoinstitutionalconflictsofinterestbetweenpharmaceuticalcompaniesandthehealthcaresectorbecomecorruptacasestudyofscholarshipdonationsbetweendepartmentofclinicalanesthesiologymieuniversityandonopharmaceuticalinjapan
AT saitohiroaki howdoinstitutionalconflictsofinterestbetweenpharmaceuticalcompaniesandthehealthcaresectorbecomecorruptacasestudyofscholarshipdonationsbetweendepartmentofclinicalanesthesiologymieuniversityandonopharmaceuticalinjapan
AT sawanotoyoaki howdoinstitutionalconflictsofinterestbetweenpharmaceuticalcompaniesandthehealthcaresectorbecomecorruptacasestudyofscholarshipdonationsbetweendepartmentofclinicalanesthesiologymieuniversityandonopharmaceuticalinjapan
AT tanimototetsuya howdoinstitutionalconflictsofinterestbetweenpharmaceuticalcompaniesandthehealthcaresectorbecomecorruptacasestudyofscholarshipdonationsbetweendepartmentofclinicalanesthesiologymieuniversityandonopharmaceuticalinjapan
AT ozieranskipiotr howdoinstitutionalconflictsofinterestbetweenpharmaceuticalcompaniesandthehealthcaresectorbecomecorruptacasestudyofscholarshipdonationsbetweendepartmentofclinicalanesthesiologymieuniversityandonopharmaceuticalinjapan